Home » Topics » Regulatory

Regulatory
RSS

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Tripedia receives FDA approval for use in the entire DTP immunization series

Sep. 6, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

Zometa approved in Canada for treatment of tumor-induced hypercalcemia

Aug. 31, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

New findings on an old drug: metformin

Aug. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...